title: Early medical abortion: a new regimen up to 49 days' gestation.
abstract: OBJECTIVE
  To evaluate a new regimen of mifepristone and misoprostol in early medical abortion up to 49 days of amenorrhoea.
  
  
  METHODS
  One hundred healthy women requesting pregnancy termination up to 49 days gestation received 200 mg mifepristone followed by 800 microg misoprostol orally 24 h later. Statistical analysis was carried out by unpaired t-test.
  
  
  RESULTS
  Ninety-six percent of patients aborted completely 4.3 h after they were given misoprostol. No significant side-effects were noted. The duration of bleeding correlated with gestational age (P-value 0.009).
  
  
  CONCLUSIONS
  This new regimen of mifepristone-misoprostol is effective in terminating early pregnancy, with shorter induction to abortion interval and greater acceptability.
authors.affiliation: Department of Obstetrics & Gynaecology, Dayanand Medical College & Hospital, Ludhiana, India. makki11@rediffmail.com
authors.forename: Taneja
authors.initials: T
authors.lastname: Ashima
authors.forename: Agrawal
authors.initials: A
authors.lastname: Vinita
authors.forename: Rajaram
authors.initials: R
authors.lastname: Shalini
mesh_terms: D000019:Abortifacient Agents / Q000008:administration & dosage*; D000028:Abortion, Induced / Q000379:methods*; D000328:Adult; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005865:Gestational Age; D006801:Humans; D015735:Mifepristone / Q000008:administration & dosage*; D016595:Misoprostol / Q000008:administration & dosage*; D011247:Pregnancy; D016896:Treatment Outcome
chemical_list: D000019:Abortifacient Agents; D016595:Misoprostol; D015735:Mifepristone